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Abstract
Reverse genetics consists in the modification of the activity of a target gene to analyse the phenotypic consequences. Four main
approaches are used toward this goal and will be explained in this review. Two of them are centered on genome alterations. Mutations
produced by random chemical or insertional mutagenesis can be screened, to recover only mutants in a specific gene of interest.
Alternatively, these alterations may be specifically targeted on a gene of interest by homologous recombination. The two other
approaches are centered on mRNA. RNA interference is a powerful method to reduce the level of gene products, while morpholino
antisense oligonucleotides alter mRNA metabolism or translation. Some model species, such as , are amenable to most ofDrosophila 
these approaches, whereas other model species are restricted to one of them. For example, in mice and yeasts gene targeting by
homologous recombination is prevalent, while in and zebrafish morpholino oligonucleotides are mainly used. Genome-wideXenopus 
collections of mutants or inactivated models obtained in several species by these approaches have been made and will help decipher
gene functions in the post-genome era.
MESH Keywords Animals ; Animals, Genetically Modified ; Gene Targeting ; Genome ; Mice ; Models, Genetic ; Oligonucleotides, Antisense ; genetics ; RNA
Interference ; Recombination, Genetic ; Zebrafish
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Introduction
Genetics relies on mutants. In conventional or forward  genetics, naturally occurring or artificially induced mutants are first identified“ ”
on the basis of their specific appearances or properties - their phenotypes. Then they are characterized by addressing several questions such
as: (i), How is the mutant phenotype transmitted throughout generations? (ii), Is the mutant phenotype due to a mutation in only one or
several genes? (iii), What is the phenotype of the progeny of two different mutants? Ultimately, the gene(s) that confer(s) the phenotype of
interest is (are) identified. Forward genetics, which essentially goes from the phenotype to the gene, has been an active field of research for
more than one-hundred years, and huge collections of spontaneous or induced mutants in several species have accumulated throughout the
20 century. Even now, trying to identify the genes whose mutations are causal in phenotypes such as complex human diseases remains ath 
challenging goal, although the recent technology breakthrough of massively parallel sequencing associated to the capture of the mapped
region should strongly lower the barriers to identify such mutations.
“Reverse  genetics has emerged more recently in the beginning of the 1980s, with the development of molecular tools that allowed”
considering an alternative genetic process. In reverse genetics, the starting point is the gene. A reverse geneticist  aims to specifically“ ”
modify a gene, or its expression, and characterize the phenotypic consequences of this modification. Since the late 1990s, tens of
eukaryotic genomes have been sequenced. Genome-wide sequencing revealed a large number of genes whose functions are unknown and
cannot be predicted. Assigning functions to these genes can be achieved through several convergent approaches: identifying the subcellular
localisations of gene products and the molecular complexes to which they belong, but also describing the phenotypes associated with their
manipulation. High-throughput reverse genetics approaches are therefore major tools in the post-genomic era. In the present review, we
will present different strategies aimed at specifically manipulating genes or gene expression in eukaryotes. summarizes theTable 1 
strategies that can be used in several model species.
Methods derived from forward genetics: random modifications of the genome and screening
A strategy to obtain stable mutants of a gene of interest is by random mutagenesis and screening of the progeny. Mutagenesis is
achieved by either the insertion of a piece of DNA (to induce insertion mutations) or by a chemical compound (to induce deletions or point
mutations). A gene screening is then performed in the progeny to identify, among hundreds of others, the individuals for which mutations
occurred by chance in the gene of interest. Although related to forward genetics, this strategy differs from it at the screening step.
Insertional mutagenesis
Exogenous pieces of DNA, such as transposons  or retroviruses, can randomly insert in a genome. If the insertion takes place within a*
gene, this can be mutagenic in several ways. However, this strategy generally leads to an incomplete loss of gene function and most
insertion mutants correspond to hypomorphic alleles  but not null alleles . Indeed, insertion within the promoter is likely to modify, but* *
seldom completely inhibit, the expression of the gene product. In the same way, if the RNA encoded by the inserted DNA is flanked by an
Biol Cell . Author manuscript
Page /2 20
upstream acceptor splice site and a downstream polyadenylation site, it behaves like a 3  terminal exon. Hence, insertion within an intron′
results in the synthesis of a truncated mRNA and a truncated protein. This gene-trap  approach also generally leads to an incomplete gene*
inactivation because a reduced amount of wild-type mRNA is still likely to be synthesized from the mutated gene (by skipping the
gene-trap cassette). Finally, insertion within the coding sequence that disrupts the open reading frame results in the synthesis of a truncated
protein with no or decreased activity.
Several strategies exist to obtain deletion mutants (generally null) from existing insertion mutants. If the mutant phenotype is a
consequence of the insertion of a transposon, this one can be mobilized  (excised) by expressing an appropriate transposase, resulting in“ ”
restoration of the wild-type phenotype. However, mobilization of the transposon may also result in the deletion of the genomic regions
initially flanking the transposon by a process referred to as imprecise mobilization. Hence, deletion mutants may be isolated from
screening the progeny of individuals where mobilization occurred. Alternative strategies to obtain deletion mutant from insertional mutants
rely on homologous recombination in (See paragraph 2.3), and FLP recombinase in flies ( ).Caenorhabditis elegans Parks et al., 2004 
Large collections of insertion mutants were generated in several model species. Regions flanking the insertion sites were characterized
by systematic sequencing ( ). Hence, a researcher who needs a mutant of a given gene would first query a database of insertionFigure 1A 
sites to try to find the gene. If no such mutant is available, screening new mutants can be considered. This is achieved by PCR using
primers localized in the gene of interest and in the inserted DNA. An amplimere is produced only if the exogenous DNA is inserted within
the gene ( ). To gain efficiency, DNAs from pools are analysed, and only members of positive pools are individually analysed (Figure 1B 
).Krysan et al., 1999 
In the plant ( ), a collection of transferred DNA (T-DNA ) mediated insertion mutantsArabidopsis thaliana A. thaliana Agrobacterium *
was described. Mutations were found in more than two-thirds of the genes ( ). Together with other independentAlonso et al., 2003 
collections ( ) there exist T-DNA mutants in a very large majority of genes.Rosso et al., 2003 A. thaliana 
In , initial collections used the Tc1 transposon ( ). A drawback of this endogenous transposon is that it isC. elegans Zwaal et al., 1993 
present in multiple copies in every strain. Nowadays, a large collection of insertion mutants is being generated with the heterologous
transposon (from fly origin), that is uniquely inserted in every strain ( ; ; Mos1 Bazopoulou and Tavernarakis, 2009 Duverger et al., 2007 
).Granger et al., 2004 
In zebrafish, insertional mutagenesis is achieved with two types of vectors, retroviruses and transposons reviewed in ([ Sivasubbu et al.,
) . For example, a collection of 525 mutants (390 genes) was generated using a retroviral vector ( ). Several2007 ] Amsterdam et al., 2004 
transposon-mediated gene-trap and enhancer-trap  approaches were also published ( ). In principle, inserting a* Sivasubbu et al., 2007 
transposon within a gene might result in insertional mutagenesis of the gene. Indeed, 2 lines (out of 14) that were generated using an
engineered ( gene-breaking ) transposon showed mutant phenotypes ( ) and it was also the case for 2 lines (out of“ ” Sivasubbu et al., 2006 
73) that were generated using the Tol2 transposon ( ). The recent identification of mutants of interest afterNagayoshi et al., 2008 
gene-breaking transposon mutagenesis and phenotypic screening ( ) suggests that large-scale screening followingPetzold et al., 2009 
insertional mutagenesis can be considered and that large collections will ultimately be available. Insertional mutagenesis was also
described in ( ) but, again, no large collection has been developed yet.Xenopus Yergeau and Mead, 2009 
Collections of insertion mutants were also developed in flies and mice ( ). In , the Berkeley GenomeTable 1 Drosophila Drosophila 
Project generated a collection of P element (a transposon) insertion strains. Independent strains corresponding to about one-thousand of
different genes were reported in the initial article ( ), and 5000 genes 5 years later ( ). OtherSpradling et al., 1999 Bellen et al., 2004 
collections were generated with alternative transposons, like ( ). In mice, a collection of 100,000piggyBac Thibault et al., 2004 
independent gene-trap ES cells (Embryonic stem cells) was generated, and it is expected that such a collection will eventually cover all the
mouse genes ( ; ). Engineered ES cells are stored frozen, and are the basis to obtain mutant miceCollins et al., 2007b Nord et al., 2006 
within some months by injecting these totipotent cells into a host embryo at the blastula stage that is reimplanted in pseudogestant females
ES cells may then contribute to all the organs of the developing embryo including germ cells. The resulting mouse is named a chimera“ ”
because its cells originate from either the host embryo or the ES cells. If germ cells derived from the ES cells participate in fertilization
they will transmit their genotype to the next generation and consequently, a mouse bearing homozygous alleles from the ES cells can be
readily obtained from the cultured cells in only two generations reviewed in ( ) .in vitro [ Capecchi, 2005 ]
Random chemical modifications of the genome and screening
Chemical or physical treatments that generate point mutations or deletions are an alternative to transposons to induce random
mutations of a genome. Deletions are relatively easy to screen by PCR using several primers hybridizing to a gene of interest. Mutants are
evidenced by a shorter PCR product (if the deletion is flanked by the primers) or an absence of PCR product (if the region hybridizing with
a primer is deleted) ( ; ). In , throughput can be increased by performingGengyo-Ando and Mitani, 2000 Jansen et al., 1997 C. elegans 
worm culture, DNA preparation and PCR in microtiter plates. Furthermore, pools of DNA, rather than individual DNAs, are screened for
the appearance of shorter PCR products, so that roughly 4000 genomes are examined in a single 96-well plate ( ). ALiu et al., 1999 
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North-american consortium ( ) and a Japanese consortium (http://celeganskoconsortium.omrf.org/ 
) are generating deletion alleles for the community.http://www.shigen.nig.ac.jp/c.elegans/index.jsp C. elegans 
To specifically generate and identify point mutations within one gene of interest, a method named TILLING ( argeting nduced T i l 
ocal esions n enomes) was developed ( ). Regions of interest are simultaneously PCR-amplified from al i g McCallum et al., 2000 
reference (non-mutated) DNA and several test DNAs. Test amplimeres are individually mixed with the reference amplimere, denatured
and annealed. If a point mutation was present within a test DNA, then duplexes with one mismatch will form. Initially, these duplexes
were detected because they presented altered retention times in denaturing HPLC ( ). To gain both throughput andMcCallum et al., 2000 
accuracy, an alternative method of screening was proposed that relies on the endonuclease Cel-I that specifically cleaves duplexes with one
mismatch ( ). After electrophoresis, test DNAs with one mutation within the amplified region are thereforeColbert et al., 2001 
characterized by the appearance of shorter fragments (cut by Cel-I, ) the size of which is a first indication of the site of theFigure 1C 
mutation. Throughput is increased by pooling test DNAs, before individually analysing every DNA from a positive pool. Recently, the
screening step of tomato mutants was made by PCR amplification of a gene of interest from a large collection of mutated DNAs and
massively parallel sequencing ( ), and similar deep sequencing might facilitate screening for point mutations in virtuallyRigola et al., 2009 
any organism.
Collections of TILLING mutants were developed in ( ), ( ), zebrafish (A. thaliana Till et al., 2003 C. elegans Gilchrist et al., 2006 Sood
; ), and ( ; ). In , aet al., 2006 Wienholds et al., 2003 Drosophila melanogaster Cooper et al., 2008 Winkler et al., 2005 Xenopus tropicalis 
proof-of-principle for TILLING was published ( ). To our knowledge, no TILLING has been reported in mice. A serviceGoda et al., 2006 
of TILLING was developed for the scientific community in , fly ( ) and zebrafish (A. thaliana http://tilling.fhcrc.org/ 
).http://www.sanger.ac.uk/Projects/D_rerio/mutres 
Limitations of random mutagenesis
As seen above, mutations by insertion of a piece of exogenous DNA results in more or less severe alleles. To obtain a mutant with
desired characteristics, it may therefore be required to screen a huge number of individuals with no guaranty that a null mutant will
eventually be obtained. In addition transposons also display non completely-random insertion profiles because of preference for integration
sites. It results that some loci are hot spots of insertions while others may be refractory to integration. Another limitation of insertion
mutagenesis in mice is that the mutants are constitutive , which is much less powerful than the conditional  mutants that will be described* *
below (Paragraph 2.5). In addition, a recent article reported unexpected gene alterations in one of the mouse ES lines, questioning the
capacity of the gene-trap approach to easily obtain mutated mice ( ).Vermeire et al., 2009 
The TILLING approach requires a high amount of mutagen. The reason for this is that a low amount of mutagen would result in a low
probability of obtaining mutants of the gene of interest and this would imply a too heavy screening. However, massive mutagenesis causes
concomitant mutations all over the genome in addition to the gene of interest. Hence, once an individual with a mutation in a gene of
interest is isolated, it has to be outcrossed  several times to remove the accompanying mutations. For example, a high-density collection of*
3712 mutants was recently developed. Each line carries a mutation on average every 89 kb, and it would be extremely difficultA. thaliana 
to recover a strain carrying a single mutation from this collection ( ).Martin et al., 2009 
Finally, a practical issue with large collections of mutants is their storage. Whereas it is quite easy to store plant seeds, or to store
frozen animals whenever possible ( ), many animals lack a convenient storage form.C. elegans 
Targeted modifications of the genome by homologous recombination
Strategies and designs of homologous recombination
Homologous recombination (HR), the process that generates crossover exchanges between non-sister chromatids upon meiosis, is one
of the main pathways used to repair potentially deleterious DNA double strand breaks (DSB) reviewed in ( ) .[ O Driscoll and Jeggo, 2006 ’ ]
It also permits gene engineering at specific chromosomal loci. The original procedure in the yeast Saccharomyces cerivisiae (S. cerevisiae)
was the specific disruption of a gene by insertion of a selection marker within its encoding region ( ). This generated aHinnen et al., 1978 
null allele of that gene. Today, thousands of genes have been invalidated by this way essentially in yeasts, mice and flies and the resulting
cells or organisms are described as knock-out (KO, ).Figure 2A 
HR can also be used to produce more subtle modifications of a gene by substituting an engineered sequence for thein vitro 
endogenous allele. This approach is referred to as knock-in (KI). A first application of KI strategies is to insert a reporter gene within the
endogenous allele. This creates a null allele by interrupting the reading frame of the targeted gene (similar to a KO), and this allows an
accurate description of gene expression pattern e.g. ( )  since the expression of the reporter gene is controlled by the[ Kress et al., 2007 ]
promoter of the targeted gene ( upper panel).Figure 2B 
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A second application of KI is to insert a tag-encoding sequence in frame with an endogenous ORF ( middle panel). WhileFigure 2B 
valid in mice ( ), this approach is efficiently used only in yeasts where several tags were fused to proteins on a genomicZhou et al., 2004 
scale. For example, the subcellular localization of yeast proteins in living cells was systematically determined by GFP tagging and
fluorescence microscopy ( ). Several fused tags correspond to epitopes  that are recognized by commercial monoclonalHuh et al., 2003 *
antibodies, allowing efficient detection and/or purification of the fusion protein. For example, the V5 epitope was fused to ~60  of the%
ORFs, and the subcellular localization of the corresponding proteins was determined by immunohistochemistry with anti-V5 antibodies (
). A widely used epitope in immunoprecipitations is Flag. Systematic Flaging  of yeast ORFs, followed byKumar et al., 2002 “ ”
immunoprecipitation with anti-Flag antibodies and identification of co-immunoprecipitated proteins by mass spectroscopy allowed global
characterization of yeast protein complexes ( ). An alternative to Flag epitope to achieve low-backgroundHo et al., 2002 
immunoprecipitations is the Tap-tag  (Tap, tandem affinity purification) ( ; ). The Tap-tag consists of“ ” Puig et al., 2001 Rigaut et al., 1999 
two peptides, encoding Calmodulin-binding peptide and Protein A, which permits highly selective isolation of fusion proteins and their
partners. As for Flag-epitope tagging, systematic tap-tagging of yeast ORFs allowed the identification of protein complexes (Gavin et al.,
; ). In addition, thanks to the presence of the Protein A moiety that interacts with immunoglobulins, Tap-tagging2002 Krogan et al., 2006 
also allowed a systematic measurement of protein expression levels in different conditions by Western blotting (Ghaemmaghami et al.,
).2003 
A third application of KI strategies is to replace the wild-type targeted gene by a mutated or orthologous allele  ( lower* Figure 2B 
panel). This is a way to study the basic consequence of a gene mutation described in human. For example, the study of two cancer
associated Polymerase  mutations in the yeast model showed that these mutations are lethal through a catastrophic increase in genomeδ
instability ( ). KI strategies are also promising in the study of evolution. For instance, exchanging the PRX1 geneDaee et al., 2009 
regulatory region between bat and mice identified a region of this gene responsible for limb length ( ). AnotherCretekos et al., 2008 
example is given by the mouse Foxp2 gene, whose humanization affected cortico-basal ganglia functions so that the generated mice
harbored qualitatively different ultrasonic vocalizations that are in agreement with the potential involvement of this gene in the evolution
of speech in human ( ).Enard et al., 2009 
HR-mediated gene engineering is achieved via targeting vectors. Since HR is a low frequency event, the targeting vectors include a
(positive) marker aimed at selecting or rapidly identifying the cells or organisms that underwent HR. Generally, selection markers
complement an auxotrophic mutation  in yeasts, confer a resistance to a specific antibiotic in the murine cells where HR is achieved (see*
paragraph 2.5), or confer an easily recognizable phenotype in flies or worms.
Initially, targeted insertions in were performed with a circular DNA targeting vector. Such a vector is fully integrated atS. cerevisiae 
the homologous locus by a single HR event leading to a duplication of the targeted gene ( ). A subsequent intrachromosomalFigure 3A 
recombination between the two copies of the targeted gene (similar to that shown in ) can lead either to the recovery of theFigure 3D 
initial sequence of the targeted gene or to the substitution by the exogenous sequence. Thereafter, it was shown in yeasts that linearization
of the circular DNA vector within the exogenous target gene increases strongly the integration process by enhancing the recombination
frequencies ( ). Such linearized DNA molecules were designed as ends-in  ( ) becauseOrr-Weaver and Szostak, 1983 “ ” Hastings et al., 1993 
the ends point toward each other when aligned with the endogenous targeted sequence ( ). Like circular DNA, ends-in moleculesFigure 3B 
lead to the duplication of the gene at the targeted locus. However, gene inactivation can be achieved with the ends-in design, if the
targeting gene is designed to be mutated in both the 5  and 3  regions. In that case, both duplicated genes are also 5  and 3  mutated and′ ′ ′ ′
inactive.
An alternative design of the linear DNA molecules in which the ends point outwards when hybridized with the targeted sequence was
named ends-out . It results in the disruption of the target gene concomitantly with the insertion of the selection marker through a double“ ”
HR event ( ). In yeasts, more subtle modifications, like point mutations, can be introduced by a two-steps procedure (Figure 3C Figure 3D 
). This requires a marker that can be successively positively then negatively selected. For example, yeasts containing the URA3 marker are
positively selected in the absence of uracil in the culture medium. However, the same gene product metabolizes 5-fluoroorotic acid into
5-fluorouracil, a toxic compound. Consequently, when the culture medium contains both uracil and 5-fluoroorotic acid, only yeasts devoid
of the URA3 marker are able to grow ( ).Boeke et al., 1984 
Systematic gene disruption in yeast
Gene disruption can be carried out directly with PCR engineered ends-out molecules that consist generally of a selection marker
flanked by two short DNA sequences homologous to the DNA target. About 40 nucleotides are sufficient in for an efficientS. cerevisiae 
HR. This approach was efficient enough to systematically invalidate the ~6200 annotated open reading frames, by substituting the targeted
genes from the start to stop codon with a kanMX4 cassette that confers resistance to the drug G418 ( ; Giaever et al., 2002 Winzeler et al.,
). Analysis of the resulting strains revealed that ~71  of the genes are not essential for growth on rich glucose medium. The1999 %
cassettes used to generate the deletion collection contain two distinct 20 nucleotide sequences on both sides that serve as unique molecular“
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bar codes  to identify and quantify each KO strain in a mixed population. These features allowed a simultaneous analysis of the growth of”
the mutant collection under different culture conditions ( ).Giaever et al., 2002 
Because yeasts can grow as haploid or diploid cells, they are a unique model to study synthetic-lethal relations between genes. Two
mutations are synthetically lethal if cells with either of the single mutations are viable while cells with both mutations are not.
Synthetic-lethal phenotypes are diagnostic of a functional interaction between the products of two genes. Combinations of synthetic-lethal
mutations can give information about the products needed to fulfill a cellular process. Strategies to seek synthetic-lethal interactions at the
genome scale have been developed reviewed in ( ) . Two deletion collections are needed, in which genes are inactivated[ Dixon et al., 2009 ]
by the insertion of cassettes conferring resistance to two different antibiotics. After crossing yeasts from these two collections, the viability
of the progeny resistant simultaneously to the two antibiotics (hence, disrupted for the two genes) is measured. In , 4000S. cerivisiae 
genetic interactions were tested. Thirty-four of them were synthetic-lethal. By extrapolating to the whole genome, this suggests that
200,000 synthetic-lethal interactions may exist ( ). Similar conclusions were drawn in (Tong et al., 2004 Schizosaccharomyces pombe S.
) ( ).pombe Roguev et al., 2008 
Gene targeting by homologous recombination in Caenorhabditis elegans
In multicellular organisms, targeted modification of the genome by HR is especially useful for the geneticist if it is achieved in germ
cells or very early embryos, so that successive matings lead to mutant organisms. In the nematode ( ),Caenorhabditis elegans C. elegans 
introduction of linear DNA into meiotic oocyte nuclei results in a low rate of HR events within the targeted gene ( ).Berezikov et al., 2004 
HR in is more widely associated with transposon-mediated insertional mutagenesis ( ). The rationale is that transposonC. elegans Table 1 
excision generates DSBs that are a site for HR. To target a mutation into a gene of interest, the first step is to get a strain with a transposon
inserted within that gene. Then, plasmids containing the targeting gene (with the appropriate modifications) are introduced into these
worms by gonadal microinjection. When the transposon is excised, the DSB is potentially repaired by HR using the targeting gene as a
template. Consequently, the modifications of the targeting gene are introduced into the genome, a process named gene conversion. As
compared with HR in yeast cells or mice, an interesting difference is that the DSB that is required for HR is localised within the targeted
gene (due to transposon excision) and not the targeting gene ( ).Figure 3E 
A proof-of-principle for this approach was first brought with endogenous transposons ( ). However, in that caseBarrett et al., 2004 
transposon excision is a very rare event in germ cells and mutator  strains (with increased rates of transposition, but also increased rates of“ ”
background spontaneous mutations) are required. Furthermore, hundreds of copies of the transposons are present in the genome and the
frequency of excision of a particular transposon is low. Alternatively, a collection of transposon uniquely inserted strains is availableMos1 
(See Paragraph 1.1). Transposon excision is achieved by a transposase whose expression is controlled by an inducible promoter. Hence,
transposition is locus-specific and user-controlled. A procedure relying on controlled excision of transposon and HR with a targetingMos1 
transgene was named TIC (Mos1 excision-induced transgene instructed gene conversion) ( ). TwoMos Robert and Bessereau, 2007 
derivatives of TIC were named SCI ( -mediated single-copy insertion) and DEL ( -mediated deletion). In Mos Mos Mos1 Mos Mos1 Mos 
SCI, excision of transposon allows single-copy insertion of a transgene ( ). DEL is used to generateMos1 Frokjaer-Jensen et al., 2008 Mos 
large (up to 25 kb) targeted deletions ( ). Accurate gene engineering is now possible for most genesFrokjaer-Jensen et al., 2010 C. elegans 
thanks to these recent approaches and to a large library of insertion mutants ( ).Mos1 Bazopoulou and Tavernarakis, 2009 
Gene targeting by homologous recombination in Drosophila
As explained above, HR is much more efficiently achieved with linear than with circular DNA molecules. In , generatingDrosophila 
linear DNA in the nuclei of early embryos was challenging. This difficulty was solved a decade ago ( ) by theRong and Golic, 2000 
combination of a site-specific recombinase (SSR) and a rare-cutting endonuclease. SSRs are a family of enzymes that are able to recognize
sites on the genome with a high specificity and to ligate two different sites after cleavage. SSR target sites are directional and depending on
their relative orientations, SSR activity can have two different consequences. If the sites are in opposite orientations, SSR causes the
inversion of the DNA between the sites while sites in the same orientation cause its excision and circularization, leading to the genomic
deletion of the sequence located between the sites ; reviewed in ( ; ) . The most frequently used[Figure 4A Birling et al., 2009 Feil, 2007 ]
SSRs and their sites are listed in . Among them, the yeast FLP recombinase catalyzes recombinations between two FRT (FLPFigure 4B 
Recombination Targets) sites.
In the pioneer article ( ), the targeting construct consisted of the ( ) gene, flanked by two FRT sites inRong and Golic, 2000 yellow  + y  +
the same orientation. The gene also contained a site for the rare-cutting endonuclease I-SceI. Transgenic flies for this construct werey  +
obtained by P-element transgenesis. They were crossed with conditionally expressing the FLP recombinase and the I-SceIDrosophila 
endonuclease. In early embryos, FLP-mediated recombination between the two FRT sites yielded an intact genomic DNA with one FRT
site, and a circular DNA that consisted of the gene and one FRT site (owing to the mechanism shown in , lower panel). They  + Figure 4A 
circular DNA was next linearized within the gene (due to I-SceI cleavage). This was expected to drive ends-in  targeting of they  + “ ”
endogenous locus. This targeting was actually observed at a rate of one for some hundreds of progeny.y 
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In that article, the consequence of HR was to duplicate a gene, which is still of limited interest for reverse geneticists. Following
articles next demonstrated that it was possible to inactivate a gene or obtain a specific allele by HR in both with the ends-in andDrosophila 
ends-out designs ( ; ). Successful HR is revealed in the progeny by an easily recognizableGong and Golic, 2003 Xie and Golic, 2004 
phenotype associated with a phenotypic marker in the targeting construct. HR is a rare event, but screening hundreds of flies to find one
that encountered such an event is possible thanks to this marker gene.
Gene targeting by homologous recombination in mice
In 2007 Mario R. Capecchi, Sir Martin J. Evans and Oliver Smithies received the Nobel Prize for their discoveries on the principles
that allowed the introduction of modifications into mice genes by using ES cells review on gene targeting in mice, ( ) .[ Capecchi, 2005 ]
Gene targeting (KO or KI) by HR is performed in ES cells before their injection into host embryos. ES cells are transfected with the
targeting construct and the cells that encountered recombination are selected on the basis of their resistance to an antibiotic conferred by
the selection marker. In contrast to yeast in which HR is the major DSB repair pathway, the non homologous end-joining pathway based
on the ligation of the two ends of a DSB is the prevalent mechanism to repair a broken chromosome in mice ( ).O Driscoll and Jeggo, 2006 ’
Consequently, illegitimate recombinations (insertion of the targeting sequence away from the targeted locus) are highly frequent in mouse
cells. To prevent them, a second (negative) selection marker is required in mice. This marker is excised only upon HR, and not upon non
homologous end-joining ( ).Figure 3C 
As promising as they appear to be, conventional (constitutive) KO and KI suffer from a number of limitations in mice. If a gene
disruption is lethal at a given age or developmental stage, it is impossible to analyse the phenotypic consequences of that disruption in
older mice. Furthermore, if a protein is ubiquitously (or at least widely) expressed, the phenotype caused by the gene invalidation may
result from an abrogated gene function in virtually any cell type or tissue and it is often difficult to identify in which cell types the
inactivation initiates the mutant phenotype. A solution was brought by the use of SSRs. The Cre recombinase, from bacteriophage P1, is
the most widely used SSR in mice because, in contrast to the wild-type yeast FLP recombinase, it is stable at 37 C. The Cre recombinase°
catalyzes a recombination between two loxP sites ( ). The conditional KO  (cKO) strategy consists first in the insertion of twoFigure 4B “ ”
loxP sites oriented in the same direction in two different introns of the targeted gene. This insertion is achieved as above by HR in ES cells
and injection of the modified cells in host embryos to obtain chimeras and finally genetically modified mice. The floxed  (flanked by two“ ”
loxP sites) allele is generally associated with a wild-type phenotype, since it only differs from the wild-type allele by two short loxP sites
(34 nucleotides) located in introns. However, in tissues where the Cre recombinase is expressed, it causes the deletion of the genomic
DNA between the two loxP sites, including the exons. If the loxP sites were localised in adequate introns, this deletion creates a null allele
for the target gene ( ; ).Collins et al., 2007a Collins et al., 2007b 
Generally, floxed mice are crossed with mice expressing the Cre recombinase specifically in certain cell types or tissues to achieve
tissue-specific inactivation in the progeny. These Cre-expressing mice can be obtained by transgenesis. In that case, the transgene consists
of the Cre gene controlled by a promoter expected to drive tissue-specific expression. Alternatively, Cre-expressing mice can be obtained
by HR in ES cells, by substituting the coding sequence of a given gene (displaying an interesting expression pattern) with the Cre coding
sequence. Hundreds of mouse strains that express the Cre recombinase in a large variety of cell types have been generated to date. These
strains are generally made available to the scientific research community ( ; http://www.emmanet.org/ 
). An International Mouse Knockout Consortium coordinates North-American andhttp://www.informatics.jax.org/recombinase.shtml 
European efforts to systematically inactivate mouse genes. The goal is to obtain thousands of ES cells with conditional (floxed) targeted
mutations. These recombined cells are stored frozen before being injected in a host embryo to finally obtain mutant mice (Collins et al.,
; ).2007a Collins et al., 2007b 
Engineered Cre recombinases were also described. The most common one is a fusion protein between the Cre protein and a modified
form of the estrogen receptor ligand binding domain ( ). This mutated estrogen receptor is unable to bind endogenousIndra et al., 1999 
estrogens, but efficiently binds, and is activated by, the drug tamoxifen. In control conditions, this fusion protein is sequestered in the
cytoplasm, through the interaction of the ligand binding domain with HSP90. Upon treatment of mice with tamoxifen, this interaction is
released and the Cre recombinase is translocated into nuclei, where recombination occurs. This system provides a means to inactivate a
given gene in a given tissue at any time.
Limitations of gene targeting by homologous recombination
HR is probably the best method to achieve gene targeting whenever it is possible. Unfortunately, only few model organisms are
amenable to this approach: yeasts, mice, flies and ( ). Consequently, other strategies for gene inactivation have to beC. elegans Table 1 
considered in other species.
Targeted gene silencing by double stranded RNAs
RNA interference in Caenorhabditis elegans…
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In 2006, Andrew Fire and Craig Mello were awarded a Nobel Prize for their discovery ( ) that in ,Fire et al., 1998 C. elegans 
exogenous double-stranded RNAs (dsRNA) could specifically and efficiently repress genes showing strong sequence identity to the
dsRNA. This property was named RNA interference (RNAi). A similar phenomenon had been previously discovered in plants and named
co-suppression ( ). Since, extensive efforts have been made to understand the genetic and biochemical bases of RNAi. ItNapoli et al., 1990 
was shown that dsRNA-mediated gene silencing occurs both at transcriptional (transcriptional repression) and post-transcriptional (mRNA
degradation and translation inhibition) levels. RNAi shares several features with endogenous miRNA (microRNA)-mediated gene
silencing. The mechanisms of RNAi are beyond the scope of this review, and the reader may refer to several reviews (Carthew and
; ; ). Briefly, small interfering RNAs (siRNAs) are the triggers ofSontheimer, 2009 Ghildiyal and Zamore, 2009 Liu and Paroo, 2010 
RNAi. They enter the cell by direct transfection, or they originate from a longer precursor (short hairpin RNA or long double-stranded
RNA). This precursor arises from transfection or in vivo transcription from a transgene ( ). siRNAs associated with RISCFigure 5A 
(RNA-induced silencing complex) cause the rapid degradation of cellular mRNAs containing a region perfectly complementary to the
siRNA, or repress the translation of cellular mRNAs with partial complementarity, resulting in either case in gene silencing ( ).Figure 5B 
siRNAs showing strong sequence identity with a gene promoter (untranscribed region) also repress transcription by epigenetic
mechanisms, but this property is only seldom used in reverse genetics.
Geneticists rapidly realized that RNAi was a highly powerful strategy for reverse genetics analyses ( ). Introducing a dsRNATable 1 
into cells can potentially silence or at least knock-down  virtually any target gene. In , this dsRNA may be introduced by direct* C. elegans 
injection into the gonad or, even easier, by soaking the worms in a dsRNA solution or feeding them with bacteria expressing dsRNA (Fire
; ; ). Systematic, genome-wide screenings were published using either of theseet al., 1998 Tabara et al., 1998 Timmons and Fire, 1998 
methods ( ; ), giving for the first time an access to the phenotypes associated with silencing of aGonczy et al., 2000 Kamath et al., 2003 
vast majority of genes in a multicellular organism. The feeding library  ( ) is now widely used by “ ” Kamath et al., 2003 C. elegans 
researchers. The easy uptake of dsRNA in also allowed some systematic analysis of genetic interactions to be undertaken. TensC. elegans 
of different null mutants were grown on thousands of different dsRNA-expressing bacteria, so as to examine the phenotypes associated
with double genetic inactivation. This led to the discovery of several hundreds of genetic interactions ( ; Byrne et al., 2007 Lehner et al.,
) reviewed in ( ) .2006 [ Dixon et al., 2009 ]
...And in other organisms
In , RNAi is most of ten achieved via a transgene containing an inverted repeat sequence ( ). Transcription of thisDrosophila Figure 5A 
transgene produces a long RNA with self-complementarity. It is processed into a long dsRNA that is finally diced in several siRNAs
against the targeted gene. RNAi was combined with the Gal4-UAS-mediated control of gene expression in to achieveDrosophila 
cell-specific inactivation of virtually any gene ( ). If a transgene contains an UAS (Upstream Activating Sequence) in itsDietzl et al., 2007 
promoter, it is expressed only in the presence of the yeast transcription factor Gal4. Therefore, cell-specific expression of the transgene is
achieved in the progeny of a cross between the transgenic fly and the appropriate driver , a fly expressing Gal4 in the desired cell type.“ ”
Since that strategy is highly popular, a large numbers of drivers with several different expression patterns are available for the scientific
community. In the above article ( ), a genome-wide collection of UAS-inverted repeats was made. Crossing aDietzl et al., 2007 Drosophila 
transgenic for an inverted repeat against a gene of interest with a tissue-specific Gal4 driver results in the inactivation of theDrosophila 
gene of interest in the cell types expressing Gal4. This and other ( ) collections arehttp://www.shigen.nig.ac.jp/fly/nigfly/index.jsp 
currently widely used by the community. Expression of a long dsRNA is also the basis for systematic inactivation of Drosophila A.
genes by RNAi ( ). The targeting sequences are based on previouslythaliana http://www.agrikola.org/index.php?o=/agrikola/html/index 
described sequence tags covering the genome ( ). The RNAi resources (and other Omics resources) in andHilson et al., 2004 A. thaliana 
other plants were recently surveyed ( ).Mochida and Shinozaki, 2010 
In mammals, long dsRNAs nonspecifically shut off translation by an interferon pathway. Hence, siRNAs, rather than long dsRNAs,
are used to avoid this interferon response ( ). In mammalian cultured cells, RNAi can be initiated by the directElbashir et al., 2001 
transfection of siRNAs or the expression of short hairpin  RNAs (shRNAs) that are transcribed from an appropriate transgene and“ ”
processed in siRNAs through the miRNA biogenesis pathway ( ). In mice, several strategies for conditional expression ofFigure 5A 
shRNA have been published. A potential advantage of these methods over gene engineering by homologous recombination would be that
they are easier to set up (they do not require manipulations of ES cells, but zygotic injection of transgenes). In one approach, the
expression of the shRNA was controlled by an engineered tetracycline promoter which made its expression dependent on doxycycline
administration ( ). In an alternative approach, the promoter governing the expression of the shRNA was interrupted by aSzulc et al., 2006 
cassette between two LoxP sites, and was therefore inactive. In cells expressing the Cre recombinase, this cassette was deleted and the
shRNA was expressed ( ). However, to date, there are few articles in which RNAi was used to silence genes inYu and McMahon, 2006 
whole mice recent review ( ) .[ Cazzin and Ring, 2009 ]
Limitations of RNAi approaches
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The RNAi approach has several drawbacks. The modifications of gene activity caused by RNAi are only poorly transmitted to the next
generation ( ), unless the interfering molecule is produced from a stably inserted transgene. Genes may be incompletelyAlcazar et al., 2008 
silenced, and the level of gene silencing is sometimes not reproducible. In , the procedure to deliver dsRNAs (injection into theC. elegans 
gonad, soaking in dsRNA solution or feeding the worms with bacteria expressing dsRNA) influences the silencing efficiency.
The major issue of RNA interference is the occurrence of off-target effects . siRNAs are able to repress translation of mRNAs sharing*
only limited sequence conservation ( ). Hence, any siRNA is likely to silence several genes in addition to the target gene. TheFigure 5B 
sequences of these off-targets are related, but not identical, to the siRNA. Consequently a mutant phenotype associated with the expression
of a siRNA may be due to the inactivation of one or several of these unknown off-targets rather than or in addition to the target gene. In
mammalian cultured cells, where siRNAs are directly transfected, several controls are therefore strongly recommended: different siRNAs
against the same gene product should cause the same phenotype, the interfering RNA must cause a reduction in the level of the targeted
gene product, and restoring the normal level of gene product (by introducing a modified transgene whose sequence does not match with
siRNAs) should restore a wild-type phenotype ( rescue  experiment).“ ”
In other organisms, long dsRNAs diced in several different siRNAs are used. Consequently, each individual siRNA is diluted by
several other siRNAs and the off-target effects of each individual siRNA are expected to be reduced as compared with those of unique
siRNAs used in mammalian cells. However, the total number of off-targets may also increase with the number of different siRNAs.
Indeed, two articles showed that off-target effects exist in cultured cells, although different prevalences were reported (Drosophila 
; ). Hence rescue experiments are required to demonstrate the specificity of RNAi. RescuingDasGupta et al., 2007 Ma et al., 2006 
transgenes harbour several mutations making them immune to RNAi. These mutations may be silent, altering the nucleotide sequence
without modifying the peptide sequence owing to the degenerate genetic code ( ). Orthologs of the targeted gene in aSchulz et al., 2009 
highly related species (like for , or for ) are also a valuableCaenorhabditis briggsae C. elegans Drosophila pseudoviridis D. melanogaster 
resource for rescuing transgenes ( ; ; ).Kondo et al., 2009 Langer et al., 2010 Sarov et al., 2006 
Antisense oligonucleotide-mediated inhibition of mRNA metabolism and translation
Morpholino antisense oligonucleotides in zebrafish and Xenopus
In antisense approaches, a RNA or a DNA oligonucleotide targets a given mRNA by nucleotide complementarity, and may inhibit its
translation via steric interference (antisense RNA) or cause its degradation through an RNase H activity that hydrolyses the RNA moiety of
RNA-DNA heteroduplexes (antisense DNA). While these approaches have met some success, they were largely supplanted by RNAi since
1998. Interestingly, the first paper on RNAi in indicates that double-stranded RNAs are far more efficient than single-stranded,C. elegans 
complementary RNA to silence a given gene ( ). However, two popular models in developmental biology, zebrafish and Fire et al., 1998 
, have not switched to RNAi for two reasons ( ). Firstly, RNAi is inefficient or non-specific in these species reviewed byXenopus Table 1 [
( ) . Secondly, morpholino  antisense oligonucleotides were introduced and proved to be more efficient thanEisen and Smith, 2008 ] “ ”
conventional DNA or RNA oligonucleotides. Morpholino oligonucleotides are characterized by morpholine rings which replace the
riboses or deoxyriboses moieties, and non-ionic phosphorodiamidate links between rings. Although mimicking true nucleotide sequences,
they are extremely resistant to nucleases. The mechanism of action of the morpholinos relies on the stability of the duplex formed on the
RNA that leads to steric hindrance.
Morpholinos (MOs) are generally microinjected into or zebrafish early embryos. Several cytoplasmic bridges connect cells inXenopus 
a zebrafish embryo, so that MO injection into any cell of an embryo up to the 8-cell stage provides ubiquitous delivery ( ).Bill et al., 2009 
In contrast, if a embryo is injected in one of the two first blastomeres, a phenotype resulting from the MO is detected only on theXenopus 
side of the embryo resulting from the injected cell, the other side being usable as an internal developmental control e.g. ([
) . Three strategies are used to specifically alter gene expression using MOs: translational repression, RNAGautier-Courteille et al., 2004 ]
processing modification or target protection.
Translational inhibition by Morpholinos
Morpholino-mediated translational inhibition uses antisense MOs directed to the 5  untranslated region or the sequence spanning the′
start codon of an mRNA , reviewed by ( ) . While non-demonstrated, it is assumed that they act by[Figure 6A Eisen and Smith, 2008 ]
interfering with the scanning of the small ribosomal subunit. A morpholino directed against the coding region has essentially no effect,
probably because translating ribosomes are able to strip the morpholino off the mRNA. This feature is important since it reduces (but does
not eliminate, see below) the off-target effects. Middle-scale phenotypic screens using translation-blocking MOs were reported both in
zebrafish and ( ). In zebrafish, 150 genes encoding secreted proteins and 61 genes orthologous to humanXenopus tropicalis X. tropicalis 
genes expressed in hematopoietic stem cells were targeted. Distinct phenotypes were observed for 18 and 14 of them respectively (
; ). , rather than was used for a phenotypic screen ofEckfeldt et al., 2005 Pickart et al., 2006 X. tropicalis Xenopus laevis (X. laevis) 
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MO-mediated developmental defects, essentially because it is diploid (whereas is pseudotetraploid) and several genomicX. laevis 
resources were developed. Two-hundreds-and-two genes were targeted, and almost 70  of them yielded developmental phenotypes (% Rana
).et al., 2006 
Splice-inhibiting Morpholinos
Morpholinos can interfere with RNA maturation. MOs complementary to precursors of miRNAs are able to block their processing,
resulting in their depletion ( ). MOs can also alter pre-mRNA splicing by preventing the binding of snRNP to exon/intronsFlynt et al., 2007 
junctions or blocking the nucleophilic activity of the branch point adenosine present within the intron. According to the exon definition
model that prevails in vertebrates, such targeting results in the exclusion of the exon (exon skipping) from the mature mRNA ( ).Figure 6B 
However, depending on the pre-mRNA features, the action of such morpholinos can lead to the retention of the intron or to the activation
of cryptic donor or acceptor splice sites ( ).Morcos, 2007 
Splice-inhibiting MOs may be useful to understand the functions of specific mRNA isoforms, generated through alternative splicing,
by forcing splicing toward a given isoform. Furthermore, modifying the splicing pattern may result in a frameshift, leading to a premature
stop codon that in turn targets the corresponding mRNA to rapid non-sense mRNA mediated decay NMD, review ([ Rebbapragada and
) . Hence, if correctly designed, splice-inhibiting MOs can be used as an alternative to translation blocking MOs toLykke-Andersen, 2009 ]
reduce the expression of a given gene.
When the goal is to specifically reduce gene expression in or zebrafish, what are the pros and cons of translation-blockingXenopus 
and splice-inhibiting MOs? On the one hand, changes in splicing pattern can be readily measured by analysing mRNAs, either by
conventional RT-PCR procedures, or more accurately by directly quantifying the relative ratios of the different isoforms by
pyrosequencing ( ). In contrast, monitoring the effects of translation-blocking MOs requires antibodies to measure theMereau et al., 2009 
level of the targeted protein. This is an interesting feature of splice inhibiting MOs as it overcomes the unavailability of most antibodies
required for the control of translation blocking MOs. On the other hand, splice inhibiting MOs can only be designed in species whose
genome has been sequenced. This is the case for zebrafish and , but not . Finally, transcription is silentXenopus tropicalis Xenopus laevis 
in early embryos at the time of morpholinos injection, and embryos develop using maternally inherited mRNAs ( ).Davidson, 1986 
Translation blocking MOs inhibit the expression of these maternal mRNAs whereas splice inhibiting MOs only affect newly transcribed
zygotic pre-mRNAs. Hence, whether or not maternal mRNAs have to be blocked in addition to zygotic mRNAs is an argument to direct
the choice of using either translation-blocking or splice-inhibiting MOs.
Target-protectors
A third design of MOs is as target-protector. These MOs hybridize to a region of an mRNA that is normally recognized by a
regulatory molecule, such as a miRNA or an RNA-binding protein ( ). Since MOs do not activate RNase H, targeted mRNAs areFigure 6C 
not degraded. Target protector MOs relieve the regulation that is normally exerted by the miRNA or RNA-binding protein on the mRNA.
The functions of specific regulatory interactions may therefore be investigated with that strategy ( ; ).Choi et al., 2007 Cibois et al., 2010 
Target-protector MOs are also an alternative to MOs targeting intron/exons borders to modify splice patterns. MOs directed against a
splicing regulator element involved in the activation or repression of a specific exon modify splicing by preventing the interaction with a
regulatory RNA-binding proteins ( ; ).Anquetil et al., 2009 Bruno et al., 2004 
Limitations of antisense approaches
The drawbacks of MO-mediated antisense approaches are very similar to those of RNAi approach: the occurrence of non-specific
effects, a lack of transmission of the modifications of gene activity to the next generation, and the incomplete and sometimes not
reproducible gene silencing. In addition, MOs being injected in early embryos, the time frame in which these experiments can be run is
limited (if the protein encoded by the targeted mRNA is already expressed at that time, the phenotypic consequences of MO injection can
only be observed after clearance of that protein, and thus depends on the stability of the protein).
Non-specific, off-target effects of MOs have been described. In zebrafish, a relatively large number of MOs cause cell death. This
effect is non-specific, in as much as mutants of the corresponding genes do not show this phenotype. It is due to ectopic upregulation of
the p53-dependent apoptosis pathway ( ). That such non-specific effects can occur with MOs implies that several controlsRobu et al., 2007 
are required. The proposed controls ( ) are similar to those used for RNAi in cultured cells (See Paragraph 3.3): i)Eisen and Smith, 2008 
check the effect of the MO upon the expression of the targeted gene, at the mRNA (splice inhibiting MO) or protein (translation blocking
MO) level; ii) use control MOs such as MOs presenting several mismatches, depending on the number of mismatches the MO should have
a weaker activity or no activity; iii) use several MOs against the same target that should yield a similar phenotype when injected
individually, and should have a synergistic effect when co-injected; and iv) restore the wild-type phenotype by co-injecting a molecule
with the MO ( rescue  experiment). When the MO is aimed at knocking-down an mRNA, the rescuing co-injected molecule is an mRNA“ ”
encoding the same protein, but whose sequence is modified so as to avoid targeting by the MO. In a target-protection experiment where
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the protector MO inhibited the binding of a protein that directs rapid degradation, the corresponding encoded protein was overexpressed.
In that case, the rescuing molecule was a translation-blocking MO aimed at limiting that overexpression ( ).Cibois et al., 2010 
Concluding remarks
In Eukaryotes, four main strategies were elaborated to specifically modify the expression of a gene, random mutagenesis followed by
gene screening, gene engineering by homologous recombination, RNAi and antisense approaches. The decision to adopt any of these four
strategies is largely imposed by the species and the biological question being studied both of which are dependent on the particular
biological properties of each model organism ( ). Care must be taken when interpreting phenotypes, as most approaches are likelyTable 1 
to have off-target effects. Whenever possible, it would be recommended to confirm the results obtained with one approach by another
method. For species most amenable to forward genetics (zebrafish, , ), there exist collections of mutants, andDrosophila C. elegans 
comparisons can be made between the phenotypes of these mutants and the phenotypes arising from reverse genetics.
The price of reverse genetics approaches are comprised within a large range. Obtaining one custom organism with an altered
expression of a targeted gene will cost from some tens of Euros in yeast (homologous recombination with PCR products) to some
hundreds of Euros in and zebrafish (Morpholinos) and some tens of thousands of Euros in mice (gene targeting by homologousXenopus 
recombination and animal facilities). The publication, within the last decade, of several collections of targeted mutants, strongly reduces
the price of each individual mutants.
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Abbreviations
 cKO : conditional knock-out
 DSB : double-strand break
 dsRNA : double-stranded RNA
 ES : embryonic stem
 FRT : FLP recombination target
 HR : homologous recombination
 KI : Knock-in
 KO : Knock-out
 MO : Morpholino
 TIC Mos : excision-induced transgene instructed gene conversionMos1 
 RISC : RNA-induced silencing complex
 siRNA : small interfering RNA
 shRNA : short hairpin RNA
 SSR : Site-specific recombinase
 TILLING : Targeting induced local lesions in genomes
 UAS : upstream activating sequence
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Figure 1
Screening for random mutations
Large collections of insertion mutants are generated. For each mutant, the regions flanking the transposon are sequenced, to identify theA, 
site of insertion. , After transposon insertional mutagenesis, screening is achieved by PCR using one primer that hybridizes in theB 
transposon and another that hybridizes in the gene of interest. A PCR product will be obtained only if the transposon is inserted by chance in
the gene of interest. To increase throughput, mutants are first tested in pools, then individually for mutants that belong to positive pools. ,C 
TILLING. Regions of interest are simultaneously PCR-amplified from a reference (wild-type) individual and several mutants. Mutant and
wild-type amplimeres are mixed together, denatured and reannealed. If a mutation was present in the amplified region of the mutant, then a
heteroduplex with one mismatch forms. This heteroduplex is detected by the increased electrophoretic mobility after cleavage by the
endonuclease Cel-I.
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Figure 2
Diversity of gene modifications achieved by homologous recombination
Knock-Out (KO). The targeted gene is disrupted by the insertion of a selection marker. , In Knock-In (KI), a sequence of interest isA, B 
inserted within the targeted gene. If a reporter gene is inserted at an appropriate place in the targeted gene, this results in a disruption of the
targeted gene which generates a null allele, very much like KO (upper panel). Alternatively, the inserted sequence may be a tag (middle
panel). The spatio-temporal expression of the tagged protein is the same as that of the wild-type protein in control cells. Finally, the wild-type
allele may be replaced by an engineered, mutant allele (stars, lower panel).
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Figure 3
Designs for gene targeting by homologous recombination
Recombination (cross) occurs at any place within the region of homology designated by an orange box. Throughout the figure, light and dark
orange colours represent the targeted and the targeting gene respectively. With a circular targeting vector, recombination results in aA, 
duplication of the gene. The two copies are most often separated by a positive selection marker, which was used to select recombinant
individuals. Importantly, if the targeting gene is both 5  and 3  truncated, both copies will be either 5  or 3  truncated. In ends-in, there is a′ ′ ′ ′ B, 
double-strand break within the targeting gene. Homologous recombination preferably takes place at this double-strand break. As for targeting
with a circular targeting vector ( ), ends-in design yields duplicated genes often separated by a positive selection marker. , In ends-out, theA C 
double-strand breaks flank the targeting gene to generate two recombination events, leading to the disruption of the targeted gene and its
replacement by the positive marker. In mice, a negative selection marker is used to counter-select the cells where the targeting gene was
inserted in the genome by non-homologous recombination. If the targeting gene is inserted randomly by non-homologous recombination
rather than at the appropriate locus by HR, then the negative selection marker is also inserted. , Subtle gene engineering in yeast cells, likeD 
the introduction of point mutations (indicated here by a star), is achieved in two steps. It requires a marker that can be either positively or
negatively selected, depending on the culture medium. The first step is the duplication of the targeted gene by ends-in design. The targeting
gene contains the appropriate point mutation. The yeast cells that encountered this duplication are positively selected by the selection marker.
The second step is a recombination between the two duplicated genes. The yeast cells that did not encounter this recombination are
counter-selected by using the selection marker. The consequence of this recombination is that yeast cells retain only one gene. Depending on
where the recombination occurred relative to the point mutation, the allele of this gene is either wild-type or mutant (as shown here). ,E 
MosTIC in . The excision of the transposon generates a DSB in the genome (targeted gene). This DSB isCaenorhabditis elegans Mos1 
repaired by gene conversion using the targeting plasmid.
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Figure 4
Site-Specific Recombinases (SSRs)
If two sites of a SSR are in relative proximity on the DNA in opposite orientations, SSR-mediated recombination between these two sitesA, 
results in an inversion of the DNA fragment between the two sites (upper panel). If the two sites are in the same orientation, SSR-mediated
recombination between these two sites results in an excision of the DNA fragment between the two sites, and the appearance of a circular
DNA corresponding to this excised fragment (lower panel). , SSRs frequently used in gene targeting, and their corresponding sites.B 
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Figure 5
RNA interference
Origin of siRNAs (small interfering RNAs). siRNAs are small double-stranded RNA molecules and are the triggers of RNAi. In culturedA, 
mammalian cells, they are directly transfected. In mammals (or in mammalian cultured cells whenever a stable expression of thein vivo 
siRNA is required), they are produced in cells by the maturation of a precursor (shRNA, short hairpin RNA) that is transcribed from a
transgene. In non-mammalian species, siRNAs arise from long double-stranded RNAs (dsRNAs) by dicing. These dsRNAs are directly
introduced into the cells ( , cultured cells) or transcribed from a transgene ( ). , Mechanisms ofC. elegans Drosophila Drosophila in vivo B 
action of siRNAs. One strand of the initially double-stranded siRNA associates with RISC (RNA-induced silencing complex), and the
RISC-RNA complex scans cellular mRNAs. In general, mRNAs with a perfect complementarity to the RNAi are rapidly degraded
endonucleolytically then exonucleolytically (upper panel) whereas mRNAs with a partial complementarity are translationnally repressed
(lower panel). In either case, siRNAs repress gene expression.
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Figure 6
Three designs of morpholinos in reverse genetics
Translation blocking. In the absence of a morpholino (left), the small ribosomal subunit scans the 5  untranslated region. The largeA, ′
ribosomal subunit is recruited at the translation initiation codon (AUG), to reconstitute a functional ribosome that translates the mRNA. If a
morpholino hybridizes in the 5  untranslated region, or in a region flanking the initiation codon (right), scanning by the small ribosomal′
subunit is impaired. Consequently, the mRNA is not translated. , Splice inhibiting. A morpholino hybridizes on the pre-mRNA at anB 
intron-exon junction (right). Consequently, this junction is no longer used and the corresponding exon (orange) is skipped. , TargetC 
protector. The mRNA binds a regulatory molecule (protein or miRNA) that controls its fate (left). If a morpholino hybridizes to the mRNA
sequence element normally bound by that molecule, binding is impaired (right). This design allows the developmental functions of regulatory
interactions to be addressed.
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Table 1
Overview of reverse genetics approaches in common laboratory species
The prevalence of every approach in the indicated model species is marked by - (no published report) to  (Genome-wide inactivations reported). See main text for references.+++
Yeast A. thaliana C. elegans Fruit fly Zebrafish Xenopus Mouse
Insertion mutagenesis − +++
Genome-wide collection
of T-DNA mutants
+++
Genome-wide collection
of mutants inMos1 
progress
+++
Genome-wide collection of P
element and piggyBac
mutants
+
Proofs-of-principle for retrovirus
and transposon-mediated
mutagenesis
+/− +++
Genome-wide
collection of
gene-trap ES cells in
progress
Random chemical
mutation and
screening
−
(used in forward, not
reverse genetics)
+++
Genome-wide collection
of TILLING mutants,
service
+
Middle-scale collection of
TILLING mutants
++
Service for the research
community
++
Service for the research community
+/−
Proof-of-principle
−
Homologous
recombination
+++
Genome-wide
collection of KO and
KI mutants
− +/−
Few examples
+
Several examples, but no
systematic approach
− − +++
Genome-wide
collection of cKO ES
cells in progress
Inserted element
mediated gene
engineering
− − ++
TIC, SCI, Mos Mos Mos 
DEL
+
Transposon-controlled
deletions
− − −
RNAi − ++ +++
Genome-wide feeding“
library”
+++
Genome-wide UAS-driven
library
− − +/−
Few examples
Morpholino − − − − ++
Middle-scale screening
++
Middle-scale
screening
